CClinicalTrials.gg
Sign In
TerminatedNCT00065234Updated Mar 28, 2017

Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

A Phase 2 interventional study of Acupuncture in Ileus and Neoplasms, sponsored by National Center for Complementary and Integrative Health (NCCIH). Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-03-28.

Sponsored by National Center for Complementary and Integrative Health (NCCIH) · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.

02

Conditions studied

  • Ileus
  • Neoplasms

Keywords

  • Colostomy
  • Ileostomy
03

In context

Ileus

124 studies on the registry are indexed under Ileus; 12 are open to participants now.

This study's enrollment of 100 is close to the median of 97 across 106 interventional studies indexed under Ileus.

Browse Ileus studies →

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH) is the lead sponsor of 218 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
  • Hospital admission must be same day as surgery

Exclusion criteria

Exclusion Criteria:

  • Incapacitating disease
  • Concurrent herbal or laxative use
  • Use of Heparin or Coumadin
  • Upper or lower extremity deformities
  • Chronic constipation prior to cancer diagnosis
  • History of cerebrovascular accident or spinal cord injury
  • Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
  • Pacemaker or metal implants
  • Concurrent alternative medicine/herbal use
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
100 participants

Interventions

  • ProcedureAcupuncture
06

Study locations

1 site
  • MD Anderson Cancer Center
    Houston, Texas 77030, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00065234
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
First posted
Jul 22, 2003
Start date
Sep 2003
Completion
May 2006
Last update
Mar 28, 2017

Study contacts

Joseph S Chiang, MD
principal investigator · M.D. Anderson Cancer Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Ileus→

Other studies from this sponsor

National Center for Complementary and Integrative Health (NCCIH)

Start the discussion